BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36805888)

  • 1. Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management.
    Tse E; Fox CP; Glover A; Yoon SE; Kim WS; Kwong YL
    Semin Hematol; 2022 Oct; 59(4):198-209. PubMed ID: 36805888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How we treat NK/T-cell lymphomas.
    Tse E; Zhao WL; Xiong J; Kwong YL
    J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies.
    Tse E; Kwong YL
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis and management of NK/T-cell lymphomas.
    Tse E; Kwong YL
    J Hematol Oncol; 2017 Apr; 10(1):85. PubMed ID: 28410601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
    Tse E; Kwong YL
    Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of natural killer-cell malignancies.
    Ishida F; Kwong YL
    Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas.
    Tse E; Au-Yeung R; Kwong YL
    Expert Rev Hematol; 2019 Nov; 12(11):927-935. PubMed ID: 31487202
    [No Abstract]   [Full Text] [Related]  

  • 10. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Kwong YL
    J Clin Exp Hematop; 2011; 51(1):21-8. PubMed ID: 21628857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How I treat NK/T-cell lymphomas.
    Tse E; Kwong YL
    Blood; 2013 Jun; 121(25):4997-5005. PubMed ID: 23652805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review on natural killer/T-cell lymphoma.
    He X; Gao Y; Li Z; Huang H
    Hematol Oncol; 2023 Apr; 41(2):221-229. PubMed ID: 34731509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.
    Kwong YL; Chan TSY; Tan D; Kim SJ; Poon LM; Mow B; Khong PL; Loong F; Au-Yeung R; Iqbal J; Phipps C; Tse E
    Blood; 2017 Apr; 129(17):2437-2442. PubMed ID: 28188133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
    Adabifirouzjaei F; Khazai B; Azami G; Shoja-E-Razavi G
    J Med Case Rep; 2021 Oct; 15(1):539. PubMed ID: 34702349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
    Chou CC; Tsao CF; Liao CK; You HL; Wang MC; Huang WT
    Exp Mol Pathol; 2021 Feb; 118():104577. PubMed ID: 33242451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic outcome of Epstein-Barr virus positive T/NK cell lymphoma in the upper aerodigestive tract.
    Hahn JS; Lee ST; Min YH; Ko YW; Yang WI; Kim GE
    Yonsei Med J; 2002 Apr; 43(2):175-82. PubMed ID: 11971211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-induced natural killer/T cell lymphoma arising in tonsil and cervical node tissue.
    Santos AT; Tong J; Steinberg A; Shemen L
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.